These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 34973929)

  • 1. Molecular Modeling Strategies of Cancer Multidrug Resistance.
    Yalcin-Ozkat G
    Drug Resist Updat; 2021 Dec; 59():100789. PubMed ID: 34973929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
    Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
    Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
    Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
    Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
    To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
    J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development.
    Choi YH; Yu AM
    Curr Pharm Des; 2014; 20(5):793-807. PubMed ID: 23688078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances on P-Glycoprotein (ABCB1) Transporter Modelling with In Silico Methods.
    Mora Lagares L; Novič M
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.
    Pérez-Tomás R
    Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR.
    Mohammad IS; He W; Yin L
    Biomed Pharmacother; 2018 Apr; 100():335-348. PubMed ID: 29453043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP-binding cassette efflux transporters and MDR in cancer.
    Pote MS; Gacche RN
    Drug Discov Today; 2023 May; 28(5):103537. PubMed ID: 36801375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
    Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
    Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.
    Fan YF; Zhang W; Zeng L; Lei ZN; Cai CY; Gupta P; Yang DH; Cui Q; Qin ZD; Chen ZS; Trombetta LD
    Cancer Lett; 2018 May; 421():186-198. PubMed ID: 29331420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Fourth Generation ABC Inhibitors from Natural Products: A Novel Approach to Overcome Cancer Multidrug Resistance.
    Karthikeyan S; Hoti SL
    Anticancer Agents Med Chem; 2015; 15(5):605-15. PubMed ID: 25584696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABC transporters in multi-drug resistance and ADME-Tox of small molecule tyrosine kinase inhibitors.
    Deng J; Shao J; Markowitz JS; An G
    Pharm Res; 2014 Sep; 31(9):2237-55. PubMed ID: 24842659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies.
    Li W; Zhang H; Assaraf YG; Zhao K; Xu X; Xie J; Yang DH; Chen ZS
    Drug Resist Updat; 2016 Jul; 27():14-29. PubMed ID: 27449595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets.
    Kopecka J; Trouillas P; Gašparović AČ; Gazzano E; Assaraf YG; Riganti C
    Drug Resist Updat; 2020 Mar; 49():100670. PubMed ID: 31846838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigational ABC transporter inhibitors.
    Falasca M; Linton KJ
    Expert Opin Investig Drugs; 2012 May; 21(5):657-66. PubMed ID: 22493979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming multidrug resistance through targeting ABC transporters: lessons for drug discovery.
    Feyzizadeh M; Barfar A; Nouri Z; Sarfraz M; Zakeri-Milani P; Valizadeh H
    Expert Opin Drug Discov; 2022 Sep; 17(9):1013-1027. PubMed ID: 35996765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure based investigation on the binding interaction of transport proteins in leishmaniasis: insights from molecular simulation.
    Singh S; Mandlik V
    Mol Biosyst; 2015 May; 11(5):1251-9. PubMed ID: 25761976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ABC transporters in cancer chemotherapy.
    Sun YL; Patel A; Kumar P; Chen ZS
    Chin J Cancer; 2012 Feb; 31(2):51-7. PubMed ID: 22257384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Tetrahydroisoquinoline Scaffold in ABC Transporter Inhibitors that Act as Multidrug Resistance (MDR) Reversers.
    Teodori E; Braconi L; Manetti D; Romanelli MN; Dei S
    Curr Top Med Chem; 2022; 22(31):2535-2569. PubMed ID: 36284399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.